original ) (raw )Minimum Inhibitory Concentrations of Vancomycin and Daptomycin Against Methicillin-resistant Staphylococcus Aureus Isolated from Various Clinical Specimens: A Study from South India
Venkataramana Kandi
View PDFchevron_right
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
Ronald Jones , Amy Watters
2007
View PDFchevron_right
In VitroActivities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a Challenge Panel of Staphylococci and Enterococci, Including Vancomycin-IntermediateStaphylococcus aureusand Vancomycin-ResistantEnterococcus faecium
Amanda Smith
Microbial Drug Resistance, 2003
View PDFchevron_right
Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations
Hans Weiher
International Journal of Antimicrobial Agents, 2007
View PDFchevron_right
Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers
Fatima Lopez
Diagnostic Microbiology and Infectious Disease, 2009
View PDFchevron_right
Evaluation of Bactericidal Activities of LY333328, Vancomycin, Teicoplanin, Ampicillin-Sulbactam, Trovafloxacin, and RP59500 Alone or in Combination with Rifampin or Gentamicin against Different Strains of Vancomycin-Intermediate Staphylococcus aureus by Time-Kill Curve Methods
Ellie Hershberger
Antimicrobial Agents and Chemotherapy, 1999
View PDFchevron_right
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovaoxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods
Ellie Hershberger
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Contemporary trends in susceptibilities to older and new antimicrobial agents of clinical Staphylococcus aureus isolates from a Greek University Hospital
Maria Souli
International Journal of Antimicrobial Agents, 2010
View PDFchevron_right
Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years
Maria Appleman
Diagnostic Microbiology and Infectious Disease, 2010
View PDFchevron_right
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry
Kamal Hamed , Víctor J González Ramallo
Advances in Therapy, 2015
View PDFchevron_right
Antimicrobial susceptibility profiles of meticillin-susceptible and -resistant Staphylococcus aureus: focus on daptomycin minimum inhibitory concentrations at a tertiary care centre in Mumbai, India
camilla rodrigues
International Journal of Antimicrobial Agents, 2010
View PDFchevron_right
Antimicrobial activity of Daptomycin-a new antibiotic tested against methicilin-resistant staphylococi and vancomycin-resistant enterococi isolated in diferent Bulgarian medical centers
Tzvetan Velinov
Problems of Infectious and Parasitic Diseases
View PDFchevron_right
Comparison of Commercial Antimicrobial Susceptibility Test Methods for Testing of Staphylococcus aureus and Enterococci against Vancomycin, Daptomycin, and Linezolid
Stefan Riedel
Journal of Clinical Microbiology, 2014
View PDFchevron_right
Author's response to reviews Title:Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey Authors
Zeynep Gülay
2013
View PDFchevron_right
Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey
Ata Yalcin
BMC Infectious Diseases, 2013
View PDFchevron_right
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
Matthew Dryden
European Journal of Medical Research, 2010
View PDFchevron_right
Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections
Yoshio Takesue
Journal of Infection and Chemotherapy, 2013
View PDFchevron_right
Comparison of Vancomycin against methicillin resistant Staphylococcus aureus and methicilin sensitive S. aureus isolated at a tertiary care centre in Jaipur, India
Dr. Sakshita Agnihotri
2016
View PDFchevron_right
Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period
Banu Sancak
Journal of Antimicrobial Chemotherapy, 2013
View PDFchevron_right
Activity of vancomycin, linezolid and daptomycin against staphylococci and enterococci isolated in five Greek hospitals during a five-year period (2008-2012)
Sofia Vourli
Diagnostic Microbiology and Infectious Disease, 2015
View PDFchevron_right
In vitro study to evaluate the sensitivity to daptomycin among gram positive clinical isolates
Vemu Lakshmi
Indian Journal of Medical Microbiology, 2012
View PDFchevron_right
Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study
Müzeyyen Mamal Torun
International Journal of Antimicrobial Agents, 2005
View PDFchevron_right
Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections
Nancy Havill , Walid Shaib
International Journal of Antimicrobial Agents, 2010
View PDFchevron_right
Relevance of vancomycin susceptibility on patients outcome infected with Staphylococcus aureus
Jamal Wadi Al Ramahi MD, FIDSA
Pharmacotherapy, 2019
View PDFchevron_right
In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid, and tedizolid
Judy Natalia Jiménez-Quiceno
The Brazilian Journal of Infectious Diseases, 2017
View PDFchevron_right
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Ignace Demeyer , Scott Filler
New England Journal of Medicine, 2006
View PDFchevron_right